Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corabotase in Moderate to Severe Upper Facial Lines
NCT04821089Phase 2Active, not recruiting
- Sponsor
- Ipsen
- Start
- Apr 2021
- Primary completion
- Aug 2027
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of corabotase in upper facial lines, sponsored by Ipsen. Started Apr 2021; status: active, not recruiting.
02
Drugs
corabotase
03
Conditions
upper facial lines
Beyond the preview
Go deeper on NCT04821089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821089.